Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients
COVID-19 vaccination is recommended for multiple sclerosis patients. Disease-modifying
therapies can influence the safety and efficacy of COVID-19 vaccines. RNA, DNA, protein …
therapies can influence the safety and efficacy of COVID-19 vaccines. RNA, DNA, protein …
Administration of COVID-19 vaccines in immunocompromised patients
Since the beginning of vaccination programs against COVID-19 in different countries,
several populations such as patients with specific immunological conditions have been …
several populations such as patients with specific immunological conditions have been …
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
A Achiron, M Mandel, S Dreyer-Alster… - Therapeutic …, 2021 - journals.sagepub.com
Background and Aims: The National Multiple Sclerosis Society and other expert
organizations recommended that all patients with multiple sclerosis (MS) should be …
organizations recommended that all patients with multiple sclerosis (MS) should be …
[HTML][HTML] COVID-19 mRNA vaccination leading to CNS inflammation: a case series
M Khayat-Khoei, S Bhattacharyya, J Katz… - Journal of …, 2022 - Springer
The availability of vaccines against the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID …
(SARS-CoV-2), provides hope towards mitigation of the coronavirus disease 2019 (COVID …
[HTML][HTML] COVID-19 in patients with multiple sclerosis: associations with disease-modifying therapies
AT Reder, D Centonze, ML Naylor, A Nagpal… - CNS drugs, 2021 - Springer
Abstract Background Disease-modifying therapies (DMTs) for multiple sclerosis (MS) target
immunity and have the potential to increase the risk of severe acute respiratory syndrome …
immunity and have the potential to increase the risk of severe acute respiratory syndrome …
[HTML][HTML] Vaccination and immunotherapies in neuroimmunological diseases
A Winkelmann, M Loebermann, M Barnett… - Nature Reviews …, 2022 - nature.com
Neuroimmunological diseases and their treatment compromise the immune system, thereby
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …
increasing the risk of infections and serious illness. Consequently, vaccinations to protect …
[HTML][HTML] Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
X Wu, L Wang, L Shen, K Tang - EBioMedicine, 2022 - thelancet.com
Background COVID-19 vaccination is recommended for patients with multiple sclerosis
(pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV …
(pwMS), while disease-modifying therapies (DMTs) may influence the efficacy of SARS-CoV …
[HTML][HTML] Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic
S Dewanjee, J Vallamkondu, RS Kalra… - Molecular …, 2021 - Springer
The unremitting coronavirus disease 2019 (COVID-19) pandemic caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) marked a year-long phase …
[HTML][HTML] COVID-19 in ocrelizumab-treated people with multiple sclerosis
R Hughes, L Whitley, K Fitovski, HM Schneble… - Multiple sclerosis and …, 2021 - Elsevier
Background There are limited data on the impact of coronavirus disease 2019 (COVID-19)
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on people …
caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on people …
[HTML][HTML] Cladribine tablets for relapsing–remitting multiple sclerosis: A clinician's review
G Giovannoni, J Mathews - Neurology and therapy, 2022 - Springer
Multiple sclerosis (MS) is a chronic neurodegenerative disease characterized by
inflammation and demyelination for which there is currently no cure; therefore, the aim of …
inflammation and demyelination for which there is currently no cure; therefore, the aim of …